Related Experiment Videos
Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity
Biochemical and Biophysical Research Communications
|February 13, 1987
Abstract:
Dacarbazine induces DNA lesions in cells synthesizing new DNA. When poly(ADP-ribosylation) is inhibited with 3-aminobenzamide, repair of the dacarbazine-induced DNA lesions is reduced. This is parallelled by increased cytotoxicity. Cells pre-treated with aphidicolin (to stop DNA synthesis) are resistant to dacarbazine.
Insights
Dacarbazine causes DNA damage during DNA synthesis. Inhibiting poly(ADP-ribosylation) or stopping DNA replication increases dacarbazine
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Repair Mechanisms
Background:
- Dacarbazine is a chemotherapy drug.
- DNA damage is a key mechanism of action for many anticancer agents.
- Poly(ADP-ribosylation) is a DNA repair process.
Purpose of the Study:
- To investigate the role of poly(ADP-ribosylation) in repairing dacarbazine-induced DNA damage.
- To explore the relationship between DNA synthesis and dacarbazine sensitivity.
Main Methods:
- Treating cells with dacarbazine.
- Inhibiting poly(ADP-ribosylation) using 3-aminobenzamide.
- Inhibiting DNA synthesis using aphidicolin.
Main Results:
- Inhibition of poly(ADP-ribosylation) reduced DNA repair and increased dacarbazine cytotoxicity.
- Pre-treatment with aphidicolin rendered cells resistant to dacarbazine.
- Dacarbazine specifically targets cells undergoing DNA synthesis.
Conclusions:
- Poly(ADP-ribosylation) plays a crucial role in repairing dacarbazine-induced DNA lesions.
- Cellular resistance to dacarbazine can be achieved by halting DNA synthesis.
- Targeting DNA repair pathways may enhance dacarbazine efficacy.